Back
Brookfield Asset Management Vs. Neurogene Industry Stock Comparison
Buy
89
BAM
Brookfield Asset Management
Last Price:
56.47
Seasonality Move:
30.76%
Sell
5
NGNE
Neurogene
Last Price:
39.96
Seasonality Move:
50.43%
Buy
89
Brookfield Asset Management (BAM)
is a Buy
Is Brookfield Asset Management a Buy, Sell or Hold?
- The current Brookfield Asset Management [BAM] share price is $56.58. The Score for BAM is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- BAM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BAM Stock Price Chart
What is Brookfield Asset Management's stock price today?
-
The Brookfield Asset Management share price today is $56.58
The current trend is moderately bullish and BAM is experiencing selling pressure, which indicates risk of future bearish movement.
BAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.36 | Buy |
| Relative Strength Index (14 RSI): | 69.47 | Buy |
| Chaikin Money Flow: | -419904 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.69 - 55.79) | Buy |
| Bollinger Bands (100): | (39.23 - 50.29) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.3 | Buy |
| Relative Strength Index (14 RSI): | 39.1 | Sell |
| Chaikin Money Flow: | -346626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.29 - 61.53) | Sell |
| Bollinger Bands (100): | (34.11 - 50.51) | Sell |
BAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.36 | Buy |
| 20-day SMA: | 53.84 | Buy |
| 50-day SMA: | 49.16 | Buy |
| 200-day SMA: | 42.43 | Buy |
| 8-day EMA: | 56.11 | Buy |
| 20-day EMA: | 53.97 | Buy |
| 50-day EMA: | 50.07 | Buy |
| 200-day EMA: | 43.17 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.39 | Sell |
| 20-day SMA: | 53.17 | Sell |
| 50-day SMA: | 46.66 | Sell |
| 200-day SMA: | 38.93 | Buy |
| 8-day EMA: | 54.03 | Sell |
| 20-day EMA: | 53.18 | Sell |
| 50-day EMA: | 48.36 | Sell |
| 200-day EMA: | 38.47 | Buy |
Brookfield Asset Management Earnings Growth & BAM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.28 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Brookfield Asset Management Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||